kabutan

Solasia Pharma K.K., July-September (3Q) Net Income Loss Narrows

Wed Nov 13, 2024 4:00 pm JST Earnings

4597 Solasia Pharma K.K. 【IFRS】

Earnings Report

Solasia Pharma K.K. <4597> [TSE-G] announced its financial results (based on IFRS) after the market closed on November 13th (16:00). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) expanded to a loss of 871 million yen (compared to a loss of 768 million yen in the same period last year).

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the October to December period (4Q) is expected to turn into a profit of 196 million yen (compared to a loss of 344 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss improved to a deficit of loss of 260 million yen (compared to a loss of 331 million yen in the same period last year). However, the operating profit/loss margin drastically worsened from -445.2% in the same period last year to -3122.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 485 -1,952 -1,973 -2,049 -14.0 ー Nov 14, 2022 IFRS
Jan - Sep, 2023 602 -787 -784 -768 -4.6 ー Nov 13, 2023 IFRS
Jan - Sep, 2024 81 -892 -892 -871 -4.5 ー Nov 13, 2024 IFRS
YoY -86.5% -13.3% -13.8% -13.4% +0.9%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 88 -677 -685 -675 -4.0 0 Feb 14, 2024 IFRS
Jul - Dec, 2024 Guidance 1,303 -64 -48 -64 -0.3 0 Aug 14, 2024 IFRS
YoY +1,380.7% +90.5% +93.0% +90.5% +92.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 1,092 -2,470 -2,492 -2,548 -16.8 0 Feb 14, 2023 IFRS
Dec, 2023 617 -1,139 -1,135 -1,112 -6.6 0 Feb 14, 2024 IFRS
Dec, 2024 Guidance 1,375 -675 -675 -675 -3.1 0 May 15, 2024 IFRS
YoY +122.9% +40.7% +40.5% +39.3% +53.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 73 -325 -334 -331 -2.0 -445.2 Nov 13, 2023 IFRS
Oct - Dec, 2023 15 -352 -351 -344 -2.1 -2,346.7 Feb 14, 2024 IFRS
Jan - Mar, 2024 11 -307 -318 -310 -1.8 -2,790.9 May 15, 2024 IFRS
Apr - Jun, 2024 61 -304 -309 -301 -1.7 -498.4 Aug 14, 2024 IFRS
Jul - Sep, 2024 9 -281 -265 -260 -1.4 -3,122.2 Nov 13, 2024 IFRS
YoY -87.7% +13.5% +20.7% +21.5% +31.5%

Related Articles